Madhya Pradesh court refuses bail to Dr. Praveen Soni in cough syrup deaths involving adulterated drugs.

Discover powerful Latin Maxims and simplify complex legal terms in seconds.

Case Overview

Case Name: Dr. Praveen Soni vs. State of Madhya Pradesh

In a tragic incident of Cough Syrup Deaths, a Madhya Pradesh court refused bail to pediatrician Dr. Praveen Soni, accused of prescribing Coldrif cough syrup that allegedly led to the deaths of 24 children in Chhindwara district . The order, passed by Additional Sessions Judge Goutam Kumar Gujre at Parasia Civil Court on October 8, 2025, observed that the investigation remains incomplete and the charges are grave . The case has drawn nationwide outrage over Adulterated Drugs, prompting a Special Investigation Team (SIT) inquiry and attracting attention from the World Health Organization (WHO) regarding India’s drug safety standards .

Step into the world of justice with Courtroom Chronicles

Key Aspects

The case raises crucial questions on medical accountability, regulatory negligence and the line between professional duty and criminal liability . It examines whether a doctor prescribing a government-approved medicine can be held responsible for resultant deaths caused by contamination .

• The prosecution alleged that Dr. Soni prescribed Coldrif syrup to children below four years in violation of DGHS guidelines .
• The syrup, manufactured by Tamil Nadu-based Sresan Pharmaceuticals was found contaminated with Diethylene Glycol, a toxic chemical .
• Police claimed Dr. Soni received a 10% commission for prescribing the syrup, sold through a shop owned by his relatives .
• The defence argued that the medicine was duly approved by the Central Drugs Standard Control Organization (CDSCO) and that the doctor was falsely implicated .
• The Indian Medical Association (IMA) condemned his arrest, asserting that liability lies with the manufacturer and drug regulators .

Legal Insights

The Court relied on multiple legal provisions while evaluating the gravity of the offence . These provisions collectively govern the manufacturing, sale and prescription of Adulterated Drugs and the bail considerations in criminal cases :

• Section 274, Indian Penal Code (IPC): Punishes the adulteration of drugs rendered noxious to human life .
• Section 275, IPC : Deals with the sale of adulterated drugs likely to cause harm or death .
• Section 27(a), Drugs and Cosmetics Act, 1940: Prescribes life imprisonment or a minimum of 10 years for manufacturing or selling adulterated drugs likely to cause death .
• Section 28, Drugs and Cosmetics Act, 1940: Punishes failure to disclose the name of the manufacturer or supplier of such drugs .
• Section 437, Code of Criminal Procedure (CrPC): Empowers the court to deny bail if the offence is serious and the investigation is ongoing .

Court’s Verdict

The Madhya Pradesh court dismissed Dr. Soni’s bail plea, emphasizing the incomplete investigation and serious nature of the allegations . It held that prescribing a potentially lethal syrup to minors breached medical prudence . The Supreme Court of India later declined to entertain a PIL seeking a court-monitored probe into the Cough Syrup Deaths, leaving the matter under the SIT’s investigation .

Source – High Court of MP

Read also – Indian Penal Code (IPC)

The LawGist ensures exam success with quality notes—TPL, Current Affairs, Recent Judgments, and more. Backed by trusted resources and videos, The LawGist is every aspirant’s first choice. Discover more at thelawgist.org